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Abstract
Background Obtaining insight into patients’ preferences is important to optimize cancer care. We investigated
patients’ preferences for surgical management of esophageal cancer.
Methods We conducted a discrete choice experiment among adult patients who had undergone esophagectomy for
adenocarcinoma or squamous cell cancer of the esophagus. Patients’ preferences were quantified with regression
analysis using scenarios based on five aspects: risk of in-hospital mortality, risk of persistent symptoms, chance of
5-year survival, risk of surgical and non-surgical complications, and hospital volume of esophageal cancer surgery.
Results The response rate was 68 % (104/142). All aspects proved to influence patients’ preferences (p\ 0.05).
Persisting gastrointestinal symptoms and 5-year survival were the most important attributes, but preferences varied
between patients. On average, patients were willing to trade-off 9.5 % (CI 2.4–16.6 %) 5-year survival chance to
obtain a surgical treatment with 30 % lower risk of gastrointestinal symptoms, or 8.1 % (CI 4.0–12.2 %) 5-year
survival chance for being treated in a high instead of a low-volume hospital.
Conclusions Patients are willing to trade-off some 5-year survival chance to achieve an improvement in early
outcomes. Given the preference heterogeneity among participants, the present study underlines the importance of a
patient-tailored approach when discussing prognosis and treatment.
Introduction
Esophageal cancer is an aggressive disease, with a 15 %
overall 5-year survival rate [1]. Surgery (i.e., esophagec-
tomy) combined with neoadjuvant therapy offers the best
chances for cure but is associated with significant mortality
and morbidity rates [2]. Esophagectomy can cause trou-
blesome and persistent gastrointestinal problems and is
associated with diminished health-related quality of life
[3, 4].
From the patients’ perspective, optimal surgical man-
agement of esophageal cancer weights aspects such as
survival chance and (non-)surgical complications, and the
experience of the hospital to conduct esophagectomies. To
optimize cancer care, it is important for health care pro-
viders and policy makers to obtain insight into patients’
preferences towards surgical management for esophageal
cancer, and to elicit the trade-offs that patients make. This
insight is not only relevant to meet patients’ expectations,
but also to provide high quality and responsive care [5].
However, quantitative studies investigating patients’ pref-
erences for surgical management of esophageal cancer are
lacking.
& Esther W. de Bekker-Grob
e.debekker@erasmusmc.nl
1 Department of Public Health, Erasmus MC - University
Medical Centre Rotterdam, PO Box 2040,
3000 CA Rotterdam, The Netherlands
2 Department of Surgery, Erasmus MC - University Medical
Centre Rotterdam, Rotterdam, The Netherlands
123
World J Surg (2015) 39:2492–2499
DOI 10.1007/s00268-015-3148-8
This study investigated patients’ preferences for surgical
management of esophageal cancer and elicited the trade-
offs that patients make. We hereto performed a discrete
choice experiment (DCE), a quantitative approach that is
increasingly used in healthcare [6].
Materials and methods
Study sample and elicitation mode
We identified patients who had undergone an esophagec-
tomy for adenocarcinoma or squamous cell cancer of the
esophagus at the Erasmus MC, University Medical Centre
Rotterdam, The Netherlands. Patients who were alive and
did not have difficulties in understanding the Dutch lan-
guage were invited to participate in the study. The ques-
tionnaire and a prepaid return envelope were mailed to the
patients. After 3 weeks, non-responders were sent a
reminder. Written informed consent was obtained from all
patients. The study was approved by the Medical Ethical
Committee of the Erasmus MC—University Medical
Centre Rotterdam (MEC-2011-217).
Discrete choice experiment (DCE)
In DCEs, it is assumed that a medical intervention, such as
a surgical treatment, can be described by its characteristics
(attributes; e.g., risk of in-hospital mortality), and that
patient’s preferences for an intervention are determined by
the levels of the attributes (e.g., for risk of in-hospital
mortality: 2, 5, and 10 %) [7]. The relative importance of
attributes and the trade-offs that patients make between
them can be assessed when patients are offered a series of
choices between treatment alternatives that have different
combinations of attribute levels (see ‘‘Appendix’’ for an
example of a choice set) [8].
Attributes and attribute levels
The choice of the most relevant attributes of surgical man-
agement of esophageal cancer and their attribute levels was
based on literature [9–12], interviews with experienced
upper gastrointestinal surgeons (n = 3), and patients who
had undergone esophagectomy for esophageal cancer
(n = 6; i.e., the target group). These were in-hospital mor-
tality (chance of dying in the hospital after esophagectomy),
persistent gastrointestinal (GI) symptoms (development of
symptoms postoperatively including dysphagia, feeling of
early fullness, nausea, regurgitation, and diarrhea), 5-year
survival (chance to be alive without recurrence 5 years after
esophagectomy), morbidity (surgical and non-surgical
complications during hospital stay requiring medical or
surgical treatment), and hospital volume (annual number of
esophagectomies per hospital) (Table 1).
Study design and questionnaire
The combination of five attributes with three levels each
resulted in 243 (35) possible alternatives for surgical
management of esophageal cancer. It is not feasible to
present a single individual with all these alternatives. We
therefore reduced the design in such a way that at least all
main effects could be estimated. NGene software (http://
www.choice-metrics.com/) was used, which is capable of
generating designs that are highly efficient (i.e., maximiz-
ing D-efficiency or minimizing D-error). As a result, 24
choice sets divided over two versions of the questionnaire
were constructed [13]. Each choice set included two sur-
gical alternatives (‘‘Appendix’’). Patients were asked to
consider the two alternatives in each choice set as realistic
alternatives and to choose the alternative that appealed
most to them.
Each questionnaire started with a detailed description of
the attributes and their levels. The main part of each
questionnaire comprised 12 choice sets. Furthermore, the
following data were collected: age at completing the
questionnaire, gender, level of education, and household
situation. The questionnaire was pilot tested in an inter-
view-based setting (n = 9) to check for any problems in
interpretation and face validity.
Table 1 Attributes and attribute levels for surgical management of
esophageal cancer
Attributes Levels
In-hospital mortality 2 %
5 %
10 %
Persistent gastrointestinal
symptoms
10 %
40 %
80 %
5-year survival after
esophagectomy
20 %
35 %
50 %
Risk for postoperative
complications (morbidity)
20 %
40 %
60 %
Hospital volume Low (\10 esophagectomies per
year)
Medium (10–40
esophagectomies per year)
High ([40 esophagectomies
per year)
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Statistical analyses
The DCE was analyzed by taking each choice among the
two surgical alternatives as an observation. The observa-
tions were analyzed by a panel mixed logit model to obtain
insight into patients’ preferences and to take preference
heterogeneity as well as correlation between the choice
tasks completed by each individual into account (since
each respondent completed 12 choice tasks) [8]. After
testing for linear effects of each continuous attribute, the
following utility model was estimated:
V ¼ b0 þ b1MORTALITY
þ b2LONGTERM COMPLICATIONS
þ b3FIVE YEAR SURVIVAL þ b4MORBIDITY
þ b5HOSPITAL VOLUME MEDIUM
þ b6HOSPITAL VOLUME HIGH ð1Þ
in which the coefficients for all attributes were treated as
normally distributed random parameters.
V represents the utility (preference score) derived for an
esophageal surgical alternative. b0 is a constant and b1–b6
are coefficients that indicate the relative weight individuals
place on a certain attribute (level). The sign of a coefficient
reflects whether the attribute has a positive or negative
effect on the utility. The value of each coefficient repre-
sents the importance respondents assign to an attribute or
attribute level. A statistically significant coefficient
(p B 0.05) indicates that individuals differentiated between
one attribute (or attribute level) and another in making their
choices in the DCE. A priori, we expected all attributes to
be important. We expected that only the attribute ‘5-year
survival after esophagectomy’ and the attribute levels of
‘hospital volume’ would have a positive effect (i.e., a
positive sign).
We generated relative utility (preference) scores of
esophagectomy scenarios based on the estimated coeffi-
cients. The higher a relative utility score, the stronger the
preference for that particular scenario. Absolute values of
V, however, have no direct interpretation [14]. We calcu-
lated the preference score (i.e., the mean utility) for a base
case scenario, representing esophagectomy in a medium
volume hospital with a 5 % risk of in-hospital mortality,
40 % risk of persistent GI symptoms, 35 % chance of
5-years survival, and 40 % risk of complications (mor-
bidity). By changing one or more attribute levels, we obtain
insight how each attribute systematically affects the utility
score (and rank) relative to the base case. We took all
preference heterogeneity into account in calculating the
mean utility [15]. Finally, to investigate the willingness to
trade-off 5-year survival to achieve an improvement in one
of the other attributes, we calculated the ratios between the
coefficients of the attributes with the attribute ‘5–year
survival’ as the denominator.
Results
Respondents
The response rate to the questionnaire was 104/142 (68 %)
and 97/104 (93 %) completed the DCE task. These
respondents had a mean age of 64 years (SD = 8.8), 70 %
were men, 28 % had a higher educational level, and 81 %
lived together with a partner or family member (Table 2).
DCE results
All five attributes proved to influence patients’ preferences
for surgical management of esophageal cancer (p\ 0.05;
Table 3). The positive or negative directions of the coef-
ficients were consistent with our a priori hypotheses. The
positive sign given to the coefficient ‘5-year survival’
indicated that patients preferred a surgical management of
esophageal cancer generating an increase of 5-year survival
after esophagectomy over surgical management that gen-
erates a lower chance of 5-year survival. The negative
signs for in-hospital mortality, persistent GI symptoms, and
morbidity indicated that patients preferred a surgical
management of esophageal cancer with a low risk of
negative side effects. Patients significantly preferred a
high-volume hospital over a low-volume hospital, even
Table 2 Characteristics of respondents, who completed the discrete
choice experiment
Characteristics Respondents (n = 97)
Mean SD
Age (years) 64 8.8
Characteristics n %
Age group (years)
\60 26 27
60–69 46 47
C70 25 26
Male gender 68 70
Educational level
Lower education 31 32
Intermediate education 30 31
Higher education 27 28
Missing 9 9
Household
With partner/family member 79 81
Single 13 13
Missing 5 5
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after statistically adjusting for the other attributes related to
medical care (in-hospital mortality, persistent GI symptoms
and morbidity). All estimated standard deviations were
significant, which indicated preference heterogeneity
among patients for several attributes of surgical manage-
ment of esophageal cancer.
Utility scores and patients’ ranks for various
surgical management scenarios
The preference score (i.e., the mean utility) for the base
case scenario (esophagectomy in a medium volume hos-
pital with 5 % in-hospital mortality, 40 % persistent GI
symptoms, 35 % 5-year survival, and 40 % morbidity) was
0.67 (Table 4). In other words, the base case scenario was
ranked 13 on a list of 21 (hypothetical) surgical treatments
for esophageal cancer (Table 4). Especially an increased
chance of 5-year survival from 35 to 50 %, or a decrease in
risk of long-term GI symptoms from 40 to 10 % had a
relatively large positive impact on the utility score and thus
on the ranking score (rank 3 and 5, respectively, compared
to rank 13 for the base case, all else being equal) (Table 4,
scenarios 3 and 2, respectively). A high hospital volume
instead of a medium volume hospital had a relatively small
positive impact on the ranking (rank 12 compared to rank
13 for the base case, all else being equal) (Table 4, scenario
5). However, surgical managements that patients preferred
were not automatically associated with optimal levels for
chance of 5-year survival and (absence of) persistent GI
symptoms. Holding the chance of 5-year survival constant,
patients ranked a surgical management with a higher risk of
long-term GI symptoms higher than a surgical management
with a lower risk of long-term GI symptoms as long as the
levels for risk of in-hospital mortality, risk of surgical
complications as well as hospital volume were more opti-
mal (Table 4; scenario 15 compared with scenarios 3 or
14). Similarly, holding the risk of persistent GI symptoms
constant, patients ranked a surgical management with a
lower chance of 5-year survival higher than a surgical
management with a higher chance of 5-year survival as
long as the levels for risk of in-hospital mortality, risk of
surgical complications as well as hospital volume were
more optimal (Table 4; scenario 15 compared with sce-
narios 2 or 13). This means that patients accepted a less
effective surgical treatment or a higher risk of persistent GI
symptoms, if esophagectomy took place in a higher volume
hospital with a lower risk of in-hospital mortality and
morbidity.
Table 3 Patients’ preferences for surgical management of esophageal cancer based on a panel mixed logit model
Attributes Coefficient Mixed logit value 95 % CI
Constant Mean 0.10 (-0.20 to 0.40)
SD 0.74* (0.29 to 1.20)
In-hospital mortality (per 10 %) Mean -3.67* (-5.03 to -2.30)
SD 1.46* (0.57 to 2.35)
Persistent GI symptoms (per 10 %) Mean -0.74* (-0.95 to -0.53)
SD 0.38* (0.24 to 0.51)
5-year survival (per 10 %) Mean 2.33* (1.12 to 3.55)
SD 2.14* (1.36 to 2.92)
Morbidity (per 10 %) Mean -0.67* (-0.90 to -0.45)
SD 0.38* (0.21 to 0.54)
Hospital volume
Low (omitted) Mean -1.00* (-1.40 to -0.59)
SD
Medium Mean 0.11 (-0.16 to 0.38)
SD 0.67* (0.38 to 0.96)
High Mean 0.89* (0.55 to 1.22)
SD 0.92* (0.52 to 1.31)
Effects coded variable used for hospital volume. Normal distribution for random coefficients used on all attributes. The value of the omitted term
equals the negative sum of the coefficients of the included attribute levels
GI gastrointestinal
* p\ 0.05 for statistical significance
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Willingness to trade-off 5-year survival
Based on the expressed preferences, patients showed
their willingness to trade-off their chance of 5-year
survival to achieve an improvement in one level of the
other attributes of surgical management of esophageal
cancer (Table 5). On average, patients were willing to
trade-off 3.9 % (CI 0.6–7.3 %) 5-year survival chance to
obtain a surgical treatment with a 2.5 % lower absolute
risk of in-hospital mortality. Patients were willing to
trade-off 9.5 % (CI 2.4–16.6 %) or 5.8 % (CI
1.2–10.4 %) 5-year survival to obtain a surgical treat-
ment with 30 % lower absolute risk of GI symptoms or
20 % lower absolute risk of morbidity, respectively. For
receiving a surgical treatment in a high-volume hospital
instead of a low-volume hospital, patients were willing
to trade-off 8.1 % (CI 4.0–12.2 %) 5-year chance,
keeping other attributes constant.
Table 4 Patients’ ranks and utility scores of hypothetical surgical treatments for esophageal cancer scenarios
In-hospital
mortality (%)
Persistent GI
symptoms (%)
5-year
survival (%)
Morbidity
(%)
Hospital
volume
Utility
score
Difference in utility score
compared to base case
Rank
Base case 5 40 35 40 Medium 0.67 0.00 13
One level improvement
Scenario 1 2 40 35 40 Medium 1.90 1.23 10
Scenario 2 5 10 35 40 Medium 3.00 2.33 5
Scenario 3 5 40 50 40 Medium 4.34 3.67 3
Scenario 4 5 40 35 20 Medium 2.13 1.46 8
Scenario 5 5 40 35 40 High 1.47 0.80 12
One level worsening
Scenario 6 10 40 35 40 Medium -1.07 -1.74 17
Scenario 7 5 80 35 40 Medium -2.08 -2.75 18
Scenario 8 5 40 20 40 Medium -2.72 -3.39 20
Scenario 9 5 40 35 60 Medium -0.49 -1.16 15
Scenario 10 5 40 35 40 Low -0.31 -0.98 14
Mixed level change
Scenario 11 2 10 50 20 High 9.73 9.06 1
Scenario 12 10 10 50 20 High 6.71 6.04 2
Scenario 13 2 10 35 40 Medium 4.07 3.40 4
Scenario 14 5 80 50 20 Medium 2.89 2.22 6
Scenario 15 10 10 50 60 Low 2.21 1.54 7
Scenario 16 2 40 35 20 Low 2.08 1.41 9
Scenario 17 5 40 50 60 High 1.49 0.82 11
Scenario 18 5 40 20 20 High -0.62 -1.29 16
Scenario 19 10 10 20 40 Medium -2.37 -3.04 19
Scenario 20 10 80 20 60 Low -9.99 -10.66 21
Bold values highlight the change in attribute levels compared to the base case scenario
Table 5 Willingness to trade-off 5-year survival chance to achieve an improvement in one of the surgical management of esophageal cancer
attributes based on panel mixed logit model
Average (n = 97) Interpretation note
Willingness to trade 5-year survival (%; CI) To receive a surgical treatment for esophageal cancer
In-hospital mortality 3.9 (0.6–7.3) ….with 2.5 % less risk of in-hospital mortality
Persistent GI symptoms 9.5 (2.4–16.6) ….with 30 % less risk of persistent GI symptoms
Morbidity 5.8 (1.2–10.4) ….with 20 % less risk of morbidity
Hospital volume 8.1 (4.0–12.2) ….in a high-volume hospital instead of a low-volume hospital
The confidence intervals were determined using the Delta Method
GI gastrointestinal, CI 95 % confidence interval
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Discussion
Risk of in-hospital mortality, risk of persistent GI symp-
toms, chance of 5-year survival, risk of surgical and non-
surgical complications, and hospital volume of esophageal
cancer surgery all influenced patients’ preferences for
surgical management of esophageal cancer. Patients
accepted a less effective surgical treatment or a higher risk
of persistent GI symptoms, if esophagectomy took place in
a higher volume hospital with a lower risk of in-hospital
mortality and morbidity. Patients were willing to trade-off
9.5 % (CI 2.4–16.6 %) 5-year survival chance to obtain a
surgical treatment with 30 % lower long-term absolute risk
of GI symptoms.
Another DCE investigated preferences of patients
towards surgery for esophagogastric cancer in the UK and
found that long-term treatment outcomes (i.e., quality of
life and cure rate) outweighed attributes such as hospital
type and a surgeon’s reputation [16]. These results are in
line with our findings, which showed that especially per-
sistent GI symptoms and 5-year survival had a relatively
large impact on patients’ preferences for surgical man-
agement of esophageal cancer. Our finding that patients
were prepared to give up life expectancy to avoid side
effects of medical intervention was also found by a DCE
which focused on patients’ preferences for the management
of non-metastatic prostate cancer [17].
Patients included in our study showed preference
heterogeneity for several aspects of surgical management
of esophageal cancer. Awareness of differences in personal
values regarding surgical management is hence important.
This study underlines the importance of a patient-tailored
approach for discussing prognosis and treatment, which
may have a positive effect on the decision process and
outcomes in individual patients.
The present study had several limitations. First, although
the response rate of 68 % is similar to other DCEs per-
formed [18, 19], this response rate is still not optimal. We
cannot exclude selection bias, although the respondents did
not differ from the non-respondents in age and sex (data
not shown) and matched with the demographics of eso-
phageal cancer patients in the Netherlands [1]. Second, all
patients included in our study had experienced surgery for
esophageal cancer and therefore knew what they were
choosing for in the DCE. This strength is, however, also a
limitation. This group of patients may be biased based on
their personal experience. Therefore, a prospective study
including a pre-operative patient population is recom-
mendable to negate the effect of previous experience on
patients’ choices. Third, it is not fully clear whether
patients associate better outcome with higher volume
hospitals, and that other aspects of higher volume hospitals
are appreciated by patients. It is also possible that patients
more easily understood the concept of a high-volume
hospital than better outcomes as expressed numerically (in
%) for in-hospital mortality and morbidity. Fourth, our
study is to some extent specific to the Dutch context, that
is, a large number of people living in a small country. This
means people do not need to travel far to find a high-
volume center, and this might have impacted the volume
outcome trade-off reported. Finally, the external validity
could have been improved if patients were included who
were treated in different hospitals with different volumes.
This should be kept in mind for future research.
In conclusion, this study showed that patients are willing
to trade-off some 5-year survival chance to achieve an
improvement in early outcomes. Given the preference
heterogeneity among participants, the present study
underlines the importance of a patient-tailored approach
when discussing prognosis and treatment.
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Appendix: Example of a choice set
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